In HCC, FABP1 was shown to be a pro-tumourigenic factor that enhances angiogenesis and metastatic potential in HCC through upregulation of VEGF-A and its expression is significantly elevated in HCC tissues compared to adjacent normal tissues, with a strong positive correlation to VEGF-A levels. Here, VEGFA is linked to hepatocellular carcinoma.